Torrent Pharma Fined Rs 6.32 Lakh by NPPA for Price Violation
By Rediff Money Desk, New Delhi Oct 18, 2024 17:33
Torrent Pharmaceuticals received a demand notice of Rs 6.32 lakh from the NPPA for launching a new drug without prior price approval. The NPPA enforces drug pricing regulations in India.
New Delhi, Oct 18 (PTI) Torrent Pharmaceuticals on Friday said it has received a demand notice of Rs 6.32 lakh from the National Pharmaceutical Pricing Authority (NPPA).
The company has received the notice from NPPA under paragraph 15 of Drug Price Control Order 2013, imposing a penalty of Rs 6,32,689.
The demand notice is for the launch of a new drug wherein price approval was taken after the launch, the drug firm said in a regulatory filing.
The said order does not have any material financial impact on the company, it added.
The NPPA is mandated to fix/revise the prices of controlled bulk drugs and formulations and to enforce prices and availability of medicines in the country.
It also monitors the prices of decontrolled drugs in order to keep them at reasonable levels.
The regulator implements and enforces the provisions of the Drugs (Prices Control) Order.
It is also entrusted with the task of recovering amounts overcharged by manufacturers for controlled drugs from consumers.
The company has received the notice from NPPA under paragraph 15 of Drug Price Control Order 2013, imposing a penalty of Rs 6,32,689.
The demand notice is for the launch of a new drug wherein price approval was taken after the launch, the drug firm said in a regulatory filing.
The said order does not have any material financial impact on the company, it added.
The NPPA is mandated to fix/revise the prices of controlled bulk drugs and formulations and to enforce prices and availability of medicines in the country.
It also monitors the prices of decontrolled drugs in order to keep them at reasonable levels.
The regulator implements and enforces the provisions of the Drugs (Prices Control) Order.
It is also entrusted with the task of recovering amounts overcharged by manufacturers for controlled drugs from consumers.
Source: PTI
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 7.99 (+ 1.52)
- 58018780
- Mishtann Foods L
- 9.17 ( -5.17)
- 27555831
- Shree Securities
- 0.42 ( -6.67)
- 27309223
- AvanceTechnologies
- 0.90 ( -4.26)
- 25537567
- Rajnish Wellness
- 1.69 ( -2.87)
- 19267607
MORE NEWS
Zepto Cuts Losses, Revenue Doubles in FY24
Quick commerce firm Zepto narrowed its losses to Rs 1,248.6 crore in FY24, while...
KKR Sells 2.6% Stake in India Grid Trust for Rs...
Private equity firm KKR has sold a 2.6% stake in India Grid Trust for Rs 277 crore...
MFN Clause Suspension: India Needs Strategic...
Switzerland's suspension of the MFN clause in its tax treaty with India highlights the...